OBI — Ondine Biomedical Share News
0.000.00%
- £56.64m
- £51.45m
- CA$2.05m
RCS - Ondine Biomedical - Ondine continues commercial growth
AnnouncementREG - Ondine Biomedical - King’s College Hospital to run Steriwave pilot
AnnouncementRCS - Ondine Biomedical - Steriwave receives UAE Regulatory Approval
AnnouncementREG - AIM - AIM Notice - 08/10/2024
AnnouncementREG - Ondine Biomedical - Ondine Biomedical Reports Robust Growth in H1 2024
AnnouncementREG - Ondine Biomedical - Collaboration advances Steriwave for ICU Market
AnnouncementREG - Ondine Biomedical - Ondine secures C$5 million financing
AnnouncementREG - Ondine Biomedical - Mölnlycke® and Ondine Join Forces Against HAIs
AnnouncementREG - Ondine Biomedical - Related Party Transaction
AnnouncementREG - Ondine Biomedical - Ondine announces Board Changes
AnnouncementRCS - Ondine Biomedical - Steriwave in British Columbia Health Authorities
AnnouncementREG - Ondine Biomedical - Leeds Teaching Hospital NHS Trust to use Steriwave
AnnouncementREG - Ondine Biomedical - Result of AGM and Voting Results
AnnouncementRCS - Ondine Biomedical - Steriwave now available through NHS Supply Chain
AnnouncementREG - Ondine Biomedical - 2023 Full Year Results and Annual Report
AnnouncementREG - Ondine Biomedical - Notice of AGM and Directorate Change
AnnouncementREG - Ondine Biomedical - Notice of Results, Investor Presentation, and AGM
AnnouncementREG - Ondine Biomedical - NOTIFICATION OF MAJOR HOLDINGS
AnnouncementRCS - Ondine Biomedical - ECDC report shows rising HAIs and antibiotic use
Announcement